ZEB1 and pancreatic neoplasm: Furthermore, ZEB1 downregulation through HDAC class I inhibition or DNA demethylation resensitizes pancreatic cancer and osteosarcoma cells to chemotherapy (Meidhof et al, 2015; Ruh et al, 2021).